New updates have been reported about PointClickCare.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
PointClickCare has launched Study Buddy, an AI-driven research platform that transforms its extensive long-term care dataset into rapid, grant-ready evidence for academic, biopharma, and government researchers. Built on deidentified data covering more than 50 structured data points per resident per day across extended stays and linked to over 30,000 providers, 400 integration partners, and every major U.S. health plan, the platform is designed to cut research timelines from months to minutes.
Study Buddy uses natural-language queries and structured prompt engineering to generate study-ready outputs, including table shells suitable for manuscripts and grant applications, while minimizing the need for specialized technical or regulatory expertise. By centering workflows on research questions rather than data models, PointClickCare is effectively productizing its LTC data asset, potentially opening new recurring revenue streams in life sciences and health economics while reinforcing its position as a critical infrastructure provider in long-term and post-acute care analytics.